CVE-2025-53880A Path Traversal vulnerability in the tftpsync/add and tftpsync/delete scripts allows a remote attacker on an adjacent network to write or delete files on the filesystem with the privileges of the un…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
A Path Traversal vulnerability in the tftpsync/add and tftpsync/delete scripts allows a remote attacker on an adjacent network to write or delete files on the filesystem with the privileges of the unprivileged wwwrun user. Although the endpoint is unauthenticated, access is restricted to a list of allowed IP addresses.
- CVSS
- 8.7 HIGH (v4.0, NVD)CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- Weakness (CWE)
- CWE-35
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Oct 18, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://bugzilla.suse.com/show_bug.cgi?id=CVE-2025-53880
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.